'Cardiac biomarkers' diaporamas de présentation

CARDIAC BIOMARKERS

BIOCHEMISTRY

649 views • 44 slides

Y Does X Make A Difference

Y Does X Make A Difference. Myocardial Ischemia. The Three Paradoxes. 1. Women have a higher prevalence of angina compared to men, yet have an overall lower prevalence of atherosclerosis and obstructive coronary artery disease

521 views • 40 slides

Acute Coronary Syndromes

Acute Coronary Syndromes. Jason Ryan, M.D. UA + NSTEMI (life-threating but not medical emergency). STEMI (medical emergency). Acute Coronary Syndromes. Unstable Angina + Non-ST-Elevation MI + ST-Elevation MI Acute Coronary Syndromes (ACS). Acute Coronary Syndromes.

525 views • 32 slides

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome. Cost of Heart Failure to Society. Challenges/Opportunities for Utilizing Biomarkers in the Management of Heart Failure. BNP and NT-proBNP for Diagnosis or Exclusion of Heart Failure.

853 views • 30 slides

PROGNOSTIC SIGNIFICANCE OF CARDIAC BIOMARKERS IN PATIENTS WITH ACUTE PULMONARY THROMBOEMBOLISM

316 views • 18 slides

World Cardiac Biomarkers Market Forecast to 2020

Read Full Report @ http://www.bigmarketresearch.com/cardiac-biomarkers-market | Cardiac Biomarkers Market Size, Share, Analysis, Trends, Growth, Demand, and Research Report 2014-2020 @ Big Market Research | The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart.

502 views • 14 slides

Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Key Players and Forecast Till 2024

Get more information about the market: https://www.imarcgroup.com/cardiac-biomarkers-market The global cardiac biomarkers market is expected to reach a value of US$ 11.6 Billion by 2024, exhibiting a CAGR of around 9% during 2019-2024. Cardiac biomarkers help as risk stratification for various cardiovascular diseases including myocardial infraction, congestive heart failure, and acute coronary syndrome. The major reason associated with this sharp rise in the demand for cardiac biomarkers is the increasing number of patients suffering from acute coronary syndrome across the globe. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=1178&flag=B Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) 91 120 433 0800 | https://www.imarcgroup.com Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

149 views • 14 slides

World Cardiac Biomarkers Market Opportunities and Forecast

The Global cardiac biomarker market is segmented based on type, application, location of testing and geography. Based on cardiac biomarker type, the market is segmented into Creatine Kinase (CK-MB), Troponins T and I, myoglobin, BNPs, IMA and others. Troponins I and T are the highest revenue-generating segment in the overall cardiac biomarker market due to its prodigious specificity and its ability to accurately detect the cardiac events of Acute Coronary Syndrome (ACS). To get more details visit : https://www.alliedmarketresearch.com/cardiac-biomarkers-market

275 views • 10 slides

Global Nuclear Magnetic Resonance Spectrometer industry

This is a professional and depth research report on Global Nuclear Magnetic Resonance Spectrometer (NMR) industry. For overview analysis, the report introduces Nuclear Magnetic Resonance Spectrometer (NMR) basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

207 views • 9 slides

Cardiac Biomarkers Testing Market Size- KBV Research

The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is caused by a plaque formed due to atherosclerosis, which causes thrombus formation in the damaged coronary artery and results in a sudden decrease in the amount of blood and oxygen which reaches the heart. Angina is due to the reduced blood supply in the heart, and when such blood flow is interrupted for 30-60 min, it can cause necrosis of heart muscle, resulting in myocardial infarction. Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/

98 views • 9 slides

Cardiac Biomarkers Market - Global Trends & Opportunities

257 views • 8 slides

Cardiac Biomarkers Market Outlook, Consumption, Dynamics and Shares Forecasts Till 2024

Cardiac Biomarkers Market Report Includes in-depth analysis of Market Application, Size, Specification, Trends, Major Manufacturers and Business Strategies by Considering Types, Market Segmentation and Analysis.

57 views • 5 slides

48 views • 4 slides

Cardiac Marker Testing Market Share, Overview and Cost Structure Analysis Report 2022

Growing prevalence of cardiovascular diseases, rapidly growing geriatric population and growing funds from private-public funded organizations to conduct ongoing trials are fueling the growth of cardiac markers testing market.

61 views • 4 slides

Cardiac Marker Testing Market Is Portraying Exponential Growth At A High CAGR In Forthcoming Period 2018-2025

The global cardiac marker testing market is portraying exponential growth at a high CAGR in forthcoming period due to growing incidence of cardiovascular diseases.Research on cardiac biomarkers and rising prevalence and incidence of cardiac disease are the major factors driving growth in cardiac marker testing markets.

47 views • 4 slides

Cardiac Marker Testing Market 2018 Analysis, Key Manufacturers, Sales, Demand and Forecasts 2025

Research on cardiac biomarkers and rising prevalence and incidence of cardiac disease are the major factors driving growth in cardiac marker testing markets. Cardiac Bio-marker diagnostic test market is used to determine the concentration of proteins also used in measuring occurrence and phase of cardiovascular disease (CVD).

44 views • 4 slides

Cardiac Biomarker Market Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast 2018-2023

Cardiac Biomarker Market, by Type (Creatine Kinase, Troponins, Myoglobin, Natriuretic Peptides, Ischemia Modified Albumin, Others), by Application (Myocardial Infraction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others), by Location of Testing (Laboratory Testing, Point of Care Testing) u2013 Global Trends, Market Size, Share, Growth, Research and Forecast 2018-2023 Visit here to know more about Cardiac Biomarker Market study https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market/

44 views • 4 slides

Global Cardiac Biomarkers Market 2014-2018

Global Cardiac Biomarkers Market 2014-2018. Report Description. About Cardiac Biomarker

45 views • 4 slides

cardiac biomarkers

Creative diagnostics provides a wide range of Immunoassay test kits (ELISA) to diagnose different cardiac markers like, serum acute phase proteins (CRP proteins) and other Cardiac proteins.

89 views • 1 slides